Roberto Arosio
A5037361320- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiomyopathy and Myosin Studies
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Cardiac Valve Diseases and Treatments
- Neurological disorders and treatments
- Heart Failure Treatment and Management
- Cardiac Structural Anomalies and Repair
- Cardiovascular Effects of Exercise
- Chemical Reactions and Isotopes
- Health Systems, Economic Evaluations, Quality of Life
- Long-Term Effects of COVID-19
- ECG Monitoring and Analysis
- COVID-19 Clinical Research Studies
- Advanced MRI Techniques and Applications
- Textile materials and evaluations
- Environmental Science and Water Management
- Cardiovascular Health and Disease Prevention
- Italy: Economic History and Contemporary Issues
- Architecture and Computational Design
Luigi Sacco Hospital
2021-2024
ASST Fatebenefratelli Sacco
2022-2024
University of Milan
1946-2023
IRCCS Ospedale San Raffaele
2022
IRCCS Policlinico San Donato
2021
Abstract Aims Women have been historically underrepresented in implantable cardioverter-defibrillator (ICD) trials. No data on sex differences regarding subcutaneous ICDs (S-ICD) carriers described. Aim of our study was to investigate sex-related among unselected S-ICD recipients. Methods and results Consecutive patients enrolled the multicentre, international i-SUSI registry were analysed. Comparisons between sexes performed using a 1:1 propensity matching adjusted analysis for age, body...
Abstract Aims In acute heart failure (AHF), the consequences of impaired left atrial (LA) mechanics are not well understood. We aimed to define clinical trajectory LA by strain (LAS) analysis. Methods and results Eighty-five consecutive AHF patients with reduced, mildly preserved ventricular ejection fraction (LVEF) were enrolled in LAS-AHF trial underwent analysis speckle tracking echocardiography. Seventy-seven followed-up (FU) at 6 12 months. At hospital admission, discharge, months...
Catheter ablation (CA) of ventricular tachycardia (VT) has become an important tool to improve clinical outcomes in patients with appropriate transvenous implantable cardioverter defibrillator (ICD) shocks. The aim our analysis was test whether VT (VTA) impacts long-term even subcutaneous ICD (S-ICD) carriers.
(1) Background: Leadless (LL) stimulation is perceived to lower surgical, vascular, and lead-related complications compared transvenous (TV) pacemakers, yet controlled studies are lacking real-life experience non-conclusive. (2) Aim: To prospectively analyse survival complication rates in leadless versus VVIR pacemakers. (3) Methods: Prospective analysis of mortality 344 consecutive TV LL pacemaker recipients between June 2015 May 2021. Indications for pacing were “slow” AF,...
Abstract Cardiac resynchronization therapy (CRT) via biventricular pacing (BVP) is a well-established for patients with heart failure reduced ejection fraction and left bundle branch block, who remain symptomatic despite optimal medical therapy. Despite the long-standing clinical evidence, as well familiarity of cardiac electrophysiologists implantation technique, CRT BVP cannot be achieved or may result ineffective in up to one-third patients. Therefore, new alternative techniques, such...
Available reports on the post-discharge management of atrial fibrillation (AF) in COVID-19 patients are scarce. The aim this case series was to describe clinical outcomes new-onset AF referred a tertiary cardiac arrhythmia center after hospital discharge.All consecutive our for an ambulatory evaluation from 18 May 2020 15 March 2022 were retrospectively screened. Patients included current analysis if diagnosed during hospitalization and then clinic.Among 946 patients, 23 (2.4%) evaluated...
Abstract Introduction Regardless of the catheter ablation (CA) for atrial fibrillation (AF) strategy, role early recurrences during blanking period (BP) is still unclear. Our aim was to evaluate tachyarrhythmias (ATAs) BP after CA with laser‐balloon (LB) technique. Methods Consecutive patients undergoing LBCA were enrolled. Primary outcome study overall crude ATA recurrence rate BP. and in‐hospital readmissions deemed secondary outcomes. Results Two hundred twenty‐four underwent LB. Median...
Abstract Aims The third-generation laser balloon (LB3) is an established ablation device for pulmonary vein isolation (PVI) that allows direct visualization of the anatomical target. Equipped with automatic circumferential delivery modality, it aims at continuous PVI, improving both acute and clinical outcomes. We sought to evaluate efficacy LB3 using anatomical-based approach without verifying electrical isolation. Methods results Among 257 paroxysmal AF patients undergoing across four...
Atrial fibrillation (AF) and premature ventricular complexes (PVC) are common arrhythmias. We aimed to investigate AF prevalence in patients with PVC its impact on ablation outcomes.Consecutive undergoing at a single institution between 2016 2019 were included prospectively followed for 2 years. Patients severe valvular heart disease, hyperthyroidism, malignancy, alcohol use disorder advanced renal/hepatic diseases excluded. Twelve-lead electrocardiograms used diagnose assess morphology. All...
Abstract Funding Acknowledgements Type of funding sources: None. Background Left ventricular (LV) diastolic dysfunction (DD) is a hallmark hypertrophic cardiomyopathy (HCM) and its phenocopies, such as Fabry disease (FD). Together with left atrial (LA) size, LA function emerging sensitive marker the adaptive changes to backward transmission LV cardiac filling pressure, thus implementing DD assessment. Additionally, both HCM FD are characterized by primitive myopathy, but morpho-functional in...
Abstract Background Data on patients with heart failure (HF) a subcutaneous implantable cardioverter defibrillator (S–ICD) are scarce. Objective Aim of this study was to assess clinical outcomes the S–ICD in HF real–world analysis from largest European retrospective registry (ELISIR). Methods All consecutive undergoing implantation at several institutions were used for current analysis. The population classified into two groups: (classified as reduced and mid–range ejection fraction – HFrEF...
Abstract Background One of the current limitations S–ICD is relatively large size generator compared to TV (transvenous) ICD. There little evidence whether associated with an elevated risk device–related complications in patients a low body mass index (BMI). Purpose Aim this study was compare and long–term outcomes real world cohort recipients BMI <18 kg/m2 >18 kg/m2. Methods All consecutive meeting guideline indications for ICD implantation undergoing device (Boston...
Abstract Funding Acknowledgements Type of funding sources: None. Background The subcutaneous implantable cardioverter defibrillator (S-ICD) has become an alternative to transvenous ICDs (tv-ICD), especially in young patients without a need for pacing. One the current limitations S-ICD is relatively large size generator compared tv-ICDs. There little evidence whether associated with elevated risk device-related complications low body mass index (BMI). Purpose To compare and long-term outcomes...
Abstract Background Transvenous (TV) pacemakers are a well established treatment of bradyarrhythmias yet their complications, namely bleeding, infection and pneumothorax, still pose challenges to modern cardiology. This applies particularly the older patient subgroup requiring single-chamber pacing due comorbid atrial fibrillation (AF). Furthermore, conditions such as superior venous access issues, high infectious, or bleeding risk may complicate preclude transvenous lead implantation. While...
Abstract Background limited data on real-world safety and efficacy of leadless pacemakers (LPMs) in patients who underwent transvenous lead extraction (TLE) are currently available. The present study aims to assess long-term LPMs implantation following TLE, compared with LPM de novo implant patients. Methods consecutive 12 centers joining the International LEAdless PacemakEr (i-LEAPER) registry were enrolled end retrospectively considered. Patients receiving TLE (n=184) (n=995). primary...